Exploiting 4-sulphate N-acetyl galactosamine decorated gelatin nanoparticles for effective targeting to professional phagocytes in vitro and in vivo

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of drug targeting (Print)

• Publication date

  2012-11-02

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.3109/1061186X.2012.725169PMID 23020515
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose-decorated liposomes: an application in drug delivery.

  2012cited by this paper
• Development of nanocapsules bearing doxorubicin for macrophage targeting through the phosphatidylserine ligand: a system for intervention in visceral leishmaniasis.

  2012cited by this paper
• Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis

  2011cited by this paper
• Emerging trend in nano-engineered polyelectrolyte-based surrogate carriers for delivery of bioactives

  2010cited by this paper
• Particle size and activation threshold: a new dimension of danger signaling.

  2010cited by this paper
• Innate Killing of Leishmania donovani by Macrophages of the Splenic Marginal Zone Requires IRF-7

  2010cited by this paper
• Uptake of Biodegradable Gel-Assisted LBL Nanomatrix by Leishmania donovani-Infected Macrophages

  2009cited by this paper
• Augmented inhibitory effect of superoxide dismutase on superoxide anion release from macrophages by chemical modification with polysaccharide and attenuation effects on radiation-induced inflammatory cytokine expression in vitro

  2009influential reference
• Production and characterization of Hesperetin nanosuspensions for dermal delivery.

  2009cited by this paper
• Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting

  2009cited by this paper
• In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis

  2009cited by this paper
• Gelatin nanoparticle fabrication and optimization of the particle size

  2008cited by this paper
• Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.

  2008influential reference
• The effect of water-soluble chitosan on macrophage activation and the attenuation of mite allergen-induced airway inflammation.

  2008cited by this paper
• Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery.

  2007influential reference
• Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

  2006cited by this paper
• Phosphatidylserine recognition by phagocytes: a view to a kill.

  2006cited by this paper
• Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs.

  2006cited by this paper
• Therapeutic potential of nanoparticulate systems for macrophage targeting.

  2005cited by this paper
• IMPACT OF ENDOTOXIN-INDUCED CHANGES IN P-GLYCOPROTEIN EXPRESSION ON DISPOSITION OF DOXORUBICIN IN MICE

  2005cited by this paper
• Metabolite pattern of Cysticercus cellulosae metacestode from different predilection sites of swine using proton magnetic resonance spectroscopy.

  2004cited by this paper
• Intracellular delivery of drugs to macrophages.

  2003cited by this paper
• Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles for Intracellular Delivery

  2003influential reference
• Long-Circulating Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles for Intracellular Delivery

  2002cited by this paper
• Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

  2002cited by this paper
• The molecular mechanism of sulfated carbohydrate recognition by the cysteine-rich domain of mannose receptor.

  2001cited by this paper
• Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier.

  2001cited by this paper
• The Cysteine-Rich Domain of the Macrophage Mannose Receptor Is a Multispecific Lectin That Recognizes Chondroitin Sulfates a and B and Sulfated Oligosaccharides of Blood Group Lewisa and Lewisx Types in Addition to the Sulfated N-Glycans of Lutropin

  2000cited by this paper
• Desolvation process and surface characterisation of protein nanoparticles.

  2000cited by this paper
• Gelatin nanoparticles by two step desolvation--a new preparation method, surface modifications and cell uptake.

  2000influential reference
• Molecular basis of lutropin recognition by the mannose/GalNAc-4-SO4 receptor.

  2000cited by this paper
• Dynamic dialysis for the drug release evaluation from doxorubicin-gelatin nanoparticle conjugates.

  1999cited by this paper
• A direct method for the formation of peptide and carbohydrate dendrimers.

  1999cited by this paper
• A cysteine-rich domain of the "mannose" receptor mediates GalNAc-4-SO4 binding.

  1998cited by this paper
• Characterization of a mannosylphospholipid liposome system for drug targeting to alveolar macrophages

  1997cited by this paper
• Isolation of the SO4-4-GalNAcβ1,4GlcNAcβ1,2Manα-specific Receptor from Rat Liver*

  1997cited by this paper
• Leishmania, macrophages and complement: a tale of subversion and exploitation

  1997cited by this paper
• Isolation of the SO4-4-GalNAcbeta1,4GlcNAcbeta1,2Manalpha-specific receptor from rat liver.

  1997influential reference
• The Resistance to Flow of Individual Human Neutrophils in Glass Capillary Tubes with Diameters between 4.65 and 7.75 μm

  1997cited by this paper
• Cell adhesion to biomaterials: correlations between surface charge, surface roughness, adsorbed protein, and cell morphology.

  1995cited by this paper
• Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle.

  1995cited by this paper
• Receptor mediated glycotargeting.

  1995cited by this paper
• Macrophage-directed delivery of doxorubicin conjugated to neoglycoprotein using leishmaniasis as the model disease.

  1993cited by this paper
• Characterization of the murine macrophage mannose receptor: demonstration that the downregulation of receptor expression mediated by interferon-gamma occurs at the level of transcription.

  1992cited by this paper
• Potential of doxorubicin as an antileishmanial agent.

  1992cited by this paper
• A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAcβ1, 4GlcNAcβ1,2Manα that mediates rapid clearance of lutropin

  1991cited by this paper
• A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAc beta 1,4GlcNAc beta 1,2Man alpha that mediates rapid clearance of lutropin.

  1991influential reference
• Covalent coupling of doxorubicin in protein microspheres is a major determinant of tumour drug disposition.

  1991cited by this paper
• Nanoparticles--a new colloidal drug delivery system.

  1978cited by this paper

• Receptor-Assisted Nanotherapeutics for Overcoming the Blood–Brain Barrier

  2024cites this paper
• Nanotechnology in the Treatment of Diabetic Complications: A Comprehensive Narrative Review

  2021cites this paper
• Biopolymer-based materials in nanomedicine: Synthesis and characterization

  2021cites this paper
• Quality Risk Management and Quality by Design for the Development of Diclofenac Sodium Intra-articular Gelatin Microspheres

  2020cites this paper
• Mannose Receptor and Targeting Strategies

  2019cites this paper
• Engineered multifunctional biodegradable hybrid microparticles for paclitaxel delivery in cancer therapy.

  2019cites this paper
• Strategies for surface modification of gelatin-based nanoparticles.

  2019cites this paper
• Sustained release paclitaxel-loaded core-shell-structured solid lipid microparticles for intraperitoneal chemotherapy of ovarian cancer

  2019cites this paper
• Design, development and evaluation of mannosylated oral Amphotericin B nanoparticles for anti-leishmanial therapy: Oral kinetics and macrophage uptake studies

  2018cites this paper
• Fish gelatin nanoparticles and their food applications : a review

  2018cites this paper
• Hexadecylphosphocholine (Miltefosine) stabilized chitosan modified Ampholipospheres as prototype co-delivery vehicle for enhanced killing of L. donovani.

  2017cites this paper
• Vitamin E TPGS based liposomal delivery of doxorubicin in osteosarcoma cancer cells

  2017cites this paper
• Gelatin nanoparticles: a potential candidate for medical applications

  2017cites this paper
• Cytotoxicity and Genotoxicity in Human Embryonic Kidney Cells Exposed to Surface Modify Chitosan Nanoparticles Loaded with Curcumin

  2016cites this paper
• Potential in vitro and in vivo colon specific anticancer activity in a HCT-116 xenograft nude mice model: targeted delivery using enteric coated folate modified nanoparticles

  2015cites this paper
• Development of 4-sulfated N-acetyl galactosamine anchored chitosan nanoparticles: A dual strategy for effective management of Leishmaniasis.

  2015cites this paper
• Potential Use of Biological Proteins for Liver Failure Therapy

  2015cites this paper
• Chitosan coated alginate micro particles for the oral delivery of antifilarial drugs and combinations for intervention in Brugia malayi induced lymphatic filariasis

  2015cites this paper
• Improved oral bioavailability of novel Antithrombotic S002-333 via chitosan coated liposomes: A pharmacokinetic assessment

  2015cites this paper
• Gelatin-based particulate systems in ocular drug delivery

  2015cites this paper
• Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of arteether: pharmacokinetics, toxicity and antimalarial activity in mice

  2014cites this paper
• Pharmacokinetics study of arteether loaded solid lipid nanoparticles: an improved oral bioavailability in rats.

  2014cites this paper
• Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasis

  2014cites this paper
• Colon-specific delivery of curcumin by exploiting Eudragit-decorated chitosan nanoparticles in vitro and in vivo

  2013cites this paper
• Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research.

  2013cites this paper